Glycemic control (HbA1c). [clinicaltrials_resource:2a42742fdc5cb68f368ea8adf685a421]

Glycemic control (HbA1c). [clinicaltrials_resource:2a42742fdc5cb68f368ea8adf685a421]

BIAsp30 plus Metformin plus Placebo-Repaglinide. Double-Masked and randomized. Duration: 12 months.
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:2a42742fdc5cb68f368ea8adf685a421
Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes [clinicaltrials:NCT00118963]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Glycemic control (HbA1c). [clinicaltrials_resource:2a42742fdc5cb68f368ea8adf685a421]

BIAsp30 plus Metformin plus Placebo-Repaglinide. Double-Masked and randomized. Duration: 12 months.
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:2a42742fdc5cb68f368ea8adf685a421
Bio2RDF identifier
2a42742fdc5cb68f368ea8adf685a421
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2a42742fdc5cb68f368ea8adf685a421
measure [clinicaltrials_vocabulary:measure]
description
BIAsp30 plus Metformin plus Pl ...... ndomized. Duration: 12 months.
identifier
clinicaltrials_resource:2a42742fdc5cb68f368ea8adf685a421
title
Glycemic control (HbA1c).
@en
inDataset
type
label
Glycemic control (HbA1c). [clinicaltrials_resource:2a42742fdc5cb68f368ea8adf685a421]
@en